The ???packaged??? peptides of formula (I) provided by the present invention are typically administered to a mammal, particularly a human, dog or cat, any of which is intended to be encompassed by the term ???patient??? herein, in need of the prevention or treatment of diabetic retinopathy, by incorporating the selected ???packaged??? peptide in a pharmaceutical composition comprising a compound o